Goldman ID - Search Results

1

Zhao R, Goldman ID. Zhao R, et al. Among authors: goldman id. Oncogene. 2003 Oct 20;22(47):7431-57. doi: 10.1038/sj.onc.1206946. Oncogene. 2003. PMID: 14576850 Review.

2

Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathway.

Zhao R, Hanscom M, Chattopadhyay S, Goldman ID. Zhao R, et al. Among authors: goldman id. Cancer Res. 2004 May 1;64(9):3313-9. doi: 10.1158/0008-5472.can-03-3953. Cancer Res. 2004. PMID: 15126375

3

Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.

Zhao R, Chattopadhyay S, Hanscom M, Goldman ID. Zhao R, et al. Among authors: goldman id. Clin Cancer Res. 2004 Dec 15;10(24):8735-42. doi: 10.1158/1078-0432.CCR-04-0932. Clin Cancer Res. 2004. PMID: 15623659

4

The inverse relationship between reduced folate carrier function and pemetrexed activity in a human colon cancer cell line.

Chattopadhyay S, Zhao R, Krupenko SA, Krupenko N, Goldman ID. Chattopadhyay S, et al. Among authors: goldman id. Mol Cancer Ther. 2006 Feb;5(2):438-49. doi: 10.1158/1535-7163.MCT-05-0243. Mol Cancer Ther. 2006. PMID: 16505119

5

The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier.

Zhao R, Qiu A, Tsai E, Jansen M, Akabas MH, Goldman ID. Zhao R, et al. Among authors: goldman id. Mol Pharmacol. 2008 Sep;74(3):854-62. doi: 10.1124/mol.108.045443. Epub 2008 Jun 4. Mol Pharmacol. 2008. PMID: 18524888 Free PMC article.

6

The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs.

Goldman ID, Chattopadhyay S, Zhao R, Moran R. Goldman ID, et al. Curr Opin Investig Drugs. 2010 Dec;11(12):1409-23. Curr Opin Investig Drugs. 2010. PMID: 21154123 Review.

7

The antifolates.

Visentin M, Zhao R, Goldman ID. Visentin M, et al. Among authors: goldman id. Hematol Oncol Clin North Am. 2012 Jun;26(3):629-48, ix. doi: 10.1016/j.hoc.2012.02.002. Hematol Oncol Clin North Am. 2012. PMID: 22520983 Free PMC article. Review.

8

Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression.

Zhao R, Diop-Bove N, Goldman ID. Zhao R, et al. Among authors: goldman id. Mol Pharmacol. 2014 Feb;85(2):310-21. doi: 10.1124/mol.113.089110. Epub 2013 Nov 18. Mol Pharmacol. 2014. PMID: 24249723 Free PMC article.

9

Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.

Zhao R, Visentin M, Goldman ID. Zhao R, et al. Among authors: goldman id. Cancer Chemother Pharmacol. 2015 Jun;75(6):1163-73. doi: 10.1007/s00280-015-2733-8. Epub 2015 Apr 7. Cancer Chemother Pharmacol. 2015. PMID: 25847479 Free PMC article.

10

Concentrative Transport of Antifolates Mediated by the Proton-Coupled Folate Transporter (SLC46A1); Augmentation by a HEPES Buffer.

Zhao R, Najmi M, Aluri S, Spray DC, Goldman ID. Zhao R, et al. Among authors: goldman id. Mol Pharmacol. 2018 Mar;93(3):208-215. doi: 10.1124/mol.117.110445. Epub 2018 Jan 11. Mol Pharmacol. 2018. PMID: 29326243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page